[1]
|
Kovacs, J.A., et al. (1984) Pneumocystis Carinii Pneumonia: A Comparison between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies. Annals of Internal Medicine, 100, 663-671.
https://doi.org/10.7326/0003-4819-100-5-663
|
[2]
|
Beck, J.M., et al. (1991) Inflammatory Responses to Pneumocystis Carinii in Mice Selectively Depleted of Helper T Lymphocytes. American Journal of Respiratory Cell and Molecular Biology, 5, 186-197.
https://doi.org/10.1165/ajrcmb/5.2.186
|
[3]
|
Limper, A.H. and Martin, W.J. (1990) Pneumocystis Carinii: Inhibition of Lung Cell Growth Mediated by Parasite Attachment. Journal of Clinical Investigation, 85, 391-396. https://doi.org/10.1172/JCI114451
|
[4]
|
Chapman, J.R., et al. (2013) Post-Transplant Pneumocystis jirovecii Pneumonia—A Re-Emerged Public Health Problem? Kidney International, 84, 240-243. https://doi.org/10.1038/ki.2013.212
|
[5]
|
Morris, A. and Norris, K.A. (2012) Colonization by Pneumocystis jirovecii and Its Role in Disease. Clinical Microbiology Reviews, 25, 297-317. https://doi.org/10.1128/CMR.00013-12
|
[6]
|
Chen, M., et al. (2015) Pneumocystis Pneumonia in Patients with Autoimmune Diseases: A Retrospective Study Focused on Clinical Characteristics and Prognostic Factors Related to Death. PLoS ONE, 10, e0139144.
https://doi.org/10.1371/journal.pone.0139144
|
[7]
|
Saltzman, R.W., et al. (2012) Clinical Conditions Associated with PCP in Children. Pediatric Pulmonology, 47, 510-516. https://doi.org/10.1002/ppul.21577
|
[8]
|
Bienvenu, A.L., et al. (2016) Pneumocystis Pneumonia Suspected Cases in 604 Non-HIV and HIV Patients. International Journal of Infectious Diseases, 46, 11-17. https://doi.org/10.1016/j.ijid.2016.03.018
|
[9]
|
Desales, A.L., et al. (2012) Pneumocystosis in a Patient with Crohn’s Disease Treated with Combination Therapy with Adalimumab. Journal of Crohn’s and Colitis, 6, 483-487. https://doi.org/10.1016/j.crohns.2011.10.012
|
[10]
|
Baulier, G., et al. (2018) Guidelines for Prophylaxis of Pneumocystis Pneumonia Cannot Rely Solely on CD4-Cell Count in Autoimmune and Inflammatory Diseases. Clinical and Experimental Rheumatology, 36, 490-493.
|
[11]
|
Stamp, L.K. and Hurst, M. (2010) Is There a Role for Consensus Guidelines for P. jiroveci Pneumonia Prophylaxis in Immunosuppressed Patients with Rheumatic Diseases? The Journal of Rheumatology, 37, 686-688.
https://doi.org/10.3899/jrheum.091426
|
[12]
|
Park, J.W., et al. (2018) Prophylactic Effect of Trimethoprim-Sulfamethoxazole for Pneumocystis Pneumonia in Patients with Rheumatic Diseases Exposed to Prolonged High-Dose Glucocorticoids. Annals of the Rheumatic Diseases, 77, 644-649. https://doi.org/10.1136/annrheumdis-2017-211796
|
[13]
|
Salzer, H.J.F., et al. (2018) Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia. Respiration, 96, 52-65.
https://doi.org/10.1159/000487713
|
[14]
|
Akram, S., et al. (2007) Sclerosing Mesenteritis: Clinical Features, Treatment, and Outcome in Ninety-Two Patients. Clinical Gastroenterology and Hepatology, 5, 589-596. https://doi.org/10.1016/j.cgh.2007.02.032
|
[15]
|
Sharma, P., et al. (2017) Sclerosing Mesenteritis: A Systematic Review of 192 Cases. Clinical Journal of Gastroenterology, 10, 103-111. https://doi.org/10.1007/s12328-017-0716-5
|
[16]
|
Mizuno, S., et al. (2017) Increased Levels of Prostaglandin E-Major Urinary Metabolite (PGE-MUM) in Active Mesenteric Panniculitis Patients: A Case Report. Medicine (Baltimore), 96, e9237.
https://doi.org/10.1097/MD.0000000000009237
|
[17]
|
Hussein, M.R. and Abdelwahed, S.R. (2015) Mesenteric Panniculitis: An Update. Expert Review of Gastroenterology & Hepatology, 9, 67-78. https://doi.org/10.1586/17474124.2014.939632
|
[18]
|
Coulier, B., et al. (2017) Synchronous Association of Typical and Transient Mesenteric Panniculitis with Acute Gastrointestinal Attack of Adult-Onset Henoch-Schönlein Purpura. Diagnostic and Interventional Imaging, 98, 571-573.
https://doi.org/10.1016/j.diii.2017.03.002
|
[19]
|
Schmidt, J.J., et al. (2018) Clinical Course, Treatment and Outcome of Pneumocystis Pneumonia in Immunocompromised Adults: A Retrospective Analysis over 17 Years. Critical Care, 22, 307.
https://doi.org/10.1186/s13054-018-2221-8
|
[20]
|
Roux, A., et al. (2014) Pneumocystis jirovecii Pneumonia in Patients with or without AIDS, France. Emerging Infectious Diseases, 20, 1490-1497. https://doi.org/10.3201/eid2009.131668
|
[21]
|
Fillatre, P., et al. (2014) Incidence of Pneumocystis jiroveci Pneumonia among Groups at Risk in HIV-Negative Patients. The American Journal of Medicine, 127, 1242.e11-7. https://doi.org/10.1016/j.amjmed.2014.07.010
|
[22]
|
Messiaen, P.E., et al. (2017) The Role of CD4 Cell Count as Discriminatory Measure to Guide Chemoprophylaxis against Pneumocystis jirovecii Pneumonia in Human Immunodeficiency Virus-Negative Immunocompromised Patients: A Systematic Review. Transplant Infectious Disease, 19, e12651. https://doi.org/10.1111/tid.12651
|
[23]
|
Ward, M.M. and Donald, F. (1999) Pneumocystis Carinii Pneumonia in Patients with Connective Tissue Diseases: The Role of Hospital Experience in Diagnosis and Mortality. Arthritis & Rheumatology, 42, 780-789.
https://doi.org/10.1002/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M
|
[24]
|
Falagas, M.E., et al. (2007) Infection-Related Morbidity and Mortality in Patients with Connective Tissue Diseases: A Systematic Review. Clinical Rheumatology, 26, 663-670. https://doi.org/10.1007/s10067-006-0441-9
|
[25]
|
Monnet, X., et al. (2008) Critical Care Management and Outcome of Severe Pneumocystis Pneumonia in Patients with and without HIV Infection. Critical Care, 12, R28. https://doi.org/10.1186/cc6806
|
[26]
|
Grubbs, J.A. and Baddley, J.W. (2014) Pneumocystis jirovecii Pneumonia in Patients Receiving Tumor-Necrosis-Fac- tor-Inhibitor Therapy: Implications for Chemoprophylaxis. Current Rheumatology Reports, 16, 445.
https://doi.org/10.1007/s11926-014-0445-4
|
[27]
|
Martin-Garrido, I., et al. (2013) Pneumocystis Pneumonia in Patients Treated with Rituximab. Chest, 144, 258-265.
https://doi.org/10.1378/chest.12-0477
|
[28]
|
Okafor, P.N., Nunes, D.P. and Farraye, F.A. (2013) Pneumocystis jiroveci Pneumonia in Inflammatory Bowel Disease: When Should Prophylaxis Be Considered? Inflammatory Bowel Diseases, 19, 1764-1771.
https://doi.org/10.1097/MIB.0b013e318281f562
|
[29]
|
Yu, Q., et al. (2017) Outcomes and Prognostic Factors of Non-HIV Patients with Pneumocystis jirovecii Pneumonia and Pulmonary CMV Co-Infection: A Retrospective Cohort Study. BMC Infectious Diseases, 17, 392.
https://doi.org/10.1186/s12879-017-2492-8
|
[30]
|
Calero-Bernal, M.L., et al. (2016) Intermittent Courses of Corticosteroids Also Present a Risk for Pneumocystis Pneumonia in Non-HIV Patients. Canadian Respiratory Journal, 2016, Article ID: 2464791.
https://doi.org/10.1155/2016/2464791
|
[31]
|
Wasserman, S., et al. (2016) Burden of Pneumocystis Pneumonia in HIV-Infected Adults in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. BMC Infectious Diseases, 16, 482. https://doi.org/10.1186/s12879-016-1809-3
|
[32]
|
Bakeera-Kitaka, S., et al. (2004) Pneumocystis Carinii in Children with Severe Pneumonia at Mulago Hospital, Uganda. Annals of Tropical Paediatrics, 24, 227-235. https://doi.org/10.1179/027249304225019046
|
[33]
|
Stern, A., et al. (2014) Prophylaxis for Pneumocystis Pneumonia (PCP) in Non-HIV Immunocompromised Patients. Cochrane Database of Systematic Reviews, No. 10, CD005590. https://doi.org/10.1002/14651858.CD005590.pub3
|
[34]
|
Tasaka, S., et al. (2007) Serum Indicators for the Diagnosis of Pneumocystis Pneumonia. Chest, 131, 1173-1180.
https://doi.org/10.1378/chest.06-1467
|
[35]
|
Desmet, S., et al. (2009) Serum (1-3)-beta-D-glucan as a Tool for Diagnosis of Pneumocystis jirovecii Pneumonia in Patients with Human Immunodeficiency Virus Infection or Hematological Malignancy. Journal of Clinical Microbiology, 47, 3871-3874. https://doi.org/10.1128/JCM.01756-09
|
[36]
|
Mansharamani, N.G., et al. (2000) Management and Outcome Patterns for Adult Pneumocystis Carinii Pneumonia, 1985 to 1995: Comparison of HIV-Associated Cases to Other Immunocompromised States. Chest, 118, 704-711.
https://doi.org/10.1378/chest.118.3.704
|